Sorry, you need to enable JavaScript to visit this website.

First Clinical Study of a RSVpreF Vaccine in Healthy Volunteers

A Phase 1/2, Placebo-Controlled, Randomized, Observer-Blind, Dose-Finding, First-in-Human Study to Describe the Safety, Tolerability, and Immunogenicity of A Respiratory Syncytial Virus (RSV) Vaccine in Healthy Adults

Category & Conditions: Vaccine-related Conditions
Medicine: PF-06928316
ClinicalTrials.gov Identifier (NCT): NCT03529773
Protocol ID: C3671001
    Share
PrintDownload
Open Plain Language Summary Result: Click here